NCT03118583View on ClinicalTrials.gov

Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions
Healthy Volunteers
Interventions
DIETARY_SUPPLEMENT

300 mg/day of dietary supplement containing carrageenan

300 mg/day of dietary supplement containing carrageenan.

Trial Locations (1)

33487

MB Clinical Research, Boca Raton

All Listed Sponsors
lead

Midwest Center for Metabolic and Cardiovascular Research

OTHER

NCT03118583 - Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers | Biotech Hunter | Biotech Hunter